These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 2007878

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Intrauterine cocaine exposure and the risk for sudden infant death syndrome: a meta-analysis.
    Fares I, McCulloch KM, Raju TN.
    J Perinatol; 1997; 17(3):179-82. PubMed ID: 9210070
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Cocaine and the pregnant woman.
    Nair BS, Watson RR.
    J Reprod Med; 1991 Dec; 36(12):862-7. PubMed ID: 1816397
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Effect of maternal cocaine use on the fetus and newborn: review of the literature.
    Roland EH, Volpe JJ.
    Pediatr Neurosci; 1989 Dec; 15(2):88-94. PubMed ID: 2699661
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Delivery room management and outcome issues in the neonate.
    Goplerud JM.
    Curr Opin Obstet Gynecol; 1992 Dec; 4(6):826-35. PubMed ID: 1450346
    [Abstract] [Full Text] [Related]

  • 50. Biological markers and social differentiation: crack babies and the construction of the dangerous mother.
    Litt J, McNeil M.
    Health Care Women Int; 1997 Dec; 18(1):31-41. PubMed ID: 9119781
    [Abstract] [Full Text] [Related]

  • 51. Substance abuse: infant and childhood outcomes.
    D'Apolito K.
    J Pediatr Nurs; 1998 Oct; 13(5):307-16. PubMed ID: 9798367
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Use of birth defects monitoring programs for assessing the effects of maternal substance abuse on pregnancy outcomes.
    Martin ML, Edmonds LD.
    NIDA Res Monogr; 1991 Oct; 114():66-83. PubMed ID: 1754024
    [Abstract] [Full Text] [Related]

  • 56. Cocaine abuse during pregnancy: peripartum prevalence and perinatal outcome.
    Neerhof MG, MacGregor SN, Retzky SS, Sullivan TP.
    Am J Obstet Gynecol; 1989 Sep; 161(3):633-8. PubMed ID: 2782344
    [Abstract] [Full Text] [Related]

  • 57. Drug-exposed infants and children: living with a lethal legacy.
    Chabon SS, Lee-Wilkerson D, Green TJ.
    Clin Commun Disord; 1992 Sep; 2(2):32-51. PubMed ID: 1284523
    [No Abstract] [Full Text] [Related]

  • 58. Maternal and neonatal characteristics following exposure to cocaine in Toronto.
    Forman R, Klein J, Meta D, Barks J, Greenwald M, Koren G.
    Reprod Toxicol; 1993 Sep; 7(6):619-22. PubMed ID: 8118113
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Perinatal outcome associated with PCP versus cocaine use.
    Tabor BL, Smith-Wallace T, Yonekura ML.
    Am J Drug Alcohol Abuse; 1990 Sep; 16(3-4):337-48. PubMed ID: 2288331
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.